Used primarily in pharmaceutical research and development, this compound serves as a key intermediate in the synthesis of deuterated drugs. Its boronic acid group enables participation in Suzuki-Miyaura cross-coupling reactions, facilitating the creation of complex molecules with potential therapeutic applications. The deuterium labeling (d9) enhances metabolic stability, making it valuable in drug discovery for studying pharmacokinetics and improving drug efficacy. It is particularly useful in the development of targeted therapies, including cancer treatments, where precise molecular modifications are critical.